| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0cf5140a29785f5c8fdd8a3338afa22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 |
| filingDate |
2005-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb4e6958d3d65767567fc3a2841d5ffc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b287a96853085711eeaea84504ed269a |
| publicationDate |
2007-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UA-78103-C2 |
| titleOfInvention |
Use of pharmaceutical composition containing flurenizid for treating pyo-inflammatory processes in oral cavity |
| abstract |
The invention relates to the pharmaceutical composition used for the prevention and the treatment of the pyo-inflammatory processes in the oral cavity. The composition contains the following ingredients: Flurenizid 1.0 mass parts, Dimexid 49.0 mass parts, ethanol 96% to 100 mass parts. |
| priorityDate |
2005-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |